Alice Goodman Freelance writer for medical magazines, newspapers, and websites. More from Alice Prostate Cancer News Cabozantinib Plus Atezolizumab Improves Progression-Free Survival The combination of cabozantinib and atezolizumab significantly improved progression-free survival compared to second-line hormone therapy in patients with metastatic castration-resistant prostate cancer that progressed after initial hormone therapy in the CONTACT-02 trial.
More from Alice Prostate Cancer News Cabozantinib Plus Atezolizumab Improves Progression-Free Survival The combination of cabozantinib and atezolizumab significantly improved progression-free survival compared to second-line hormone therapy in patients with metastatic castration-resistant prostate cancer that progressed after initial hormone therapy in the CONTACT-02 trial.
